Copyright Reports & Markets. All rights reserved.

Global Point-of-Care Molecular Diagnostics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Point-of-Care Molecular Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 PCR-based
      • 1.4.3 Genetic Sequencing-based
      • 1.4.4 Hybridization-based
      • 1.4.5 Microarray-based
    • 1.5 Market by Application
      • 1.5.1 Global Point-of-Care Molecular Diagnostics Market Share by Application (2019-2025)
      • 1.5.2 Infectious Diseases
      • 1.5.3 Oncology
      • 1.5.4 Hematology
      • 1.5.5 Prenatal Testing
      • 1.5.6 Endocrinology
      • 1.5.7 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Point-of-Care Molecular Diagnostics Market Size
    • 2.2 Point-of-Care Molecular Diagnostics Growth Trends by Regions
      • 2.2.1 Point-of-Care Molecular Diagnostics Market Size by Regions (2019-2025)
      • 2.2.2 Point-of-Care Molecular Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Point-of-Care Molecular Diagnostics Market Size by by Players
      • 3.1.1 Global Point-of-Care Molecular Diagnostics Revenue by by Players (2014-2019)
      • 3.1.2 Global Point-of-Care Molecular Diagnostics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Point-of-Care Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Point-of-Care Molecular Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Point-of-Care Molecular Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Point-of-Care Molecular Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Point-of-Care Molecular Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Point-of-Care Molecular Diagnostics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Point-of-Care Molecular Diagnostics Market Size (2014-2019)
    • 5.2 Point-of-Care Molecular Diagnostics Key Players in North America
    • 5.3 North America Point-of-Care Molecular Diagnostics Market Size by Type
    • 5.4 North America Point-of-Care Molecular Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Point-of-Care Molecular Diagnostics Market Size (2014-2019)
    • 6.2 Point-of-Care Molecular Diagnostics Key Players in Europe
    • 6.3 Europe Point-of-Care Molecular Diagnostics Market Size by Type
    • 6.4 Europe Point-of-Care Molecular Diagnostics Market Size by Application

    7 China

    • 7.1 China Point-of-Care Molecular Diagnostics Market Size (2014-2019)
    • 7.2 Point-of-Care Molecular Diagnostics Key Players in China
    • 7.3 China Point-of-Care Molecular Diagnostics Market Size by Type
    • 7.4 China Point-of-Care Molecular Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Point-of-Care Molecular Diagnostics Market Size (2014-2019)
    • 8.2 Point-of-Care Molecular Diagnostics Key Players in Japan
    • 8.3 Japan Point-of-Care Molecular Diagnostics Market Size by Type
    • 8.4 Japan Point-of-Care Molecular Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Point-of-Care Molecular Diagnostics Market Size (2014-2019)
    • 9.2 Point-of-Care Molecular Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Type
    • 9.4 Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Application

    10 India

    • 10.1 India Point-of-Care Molecular Diagnostics Market Size (2014-2019)
    • 10.2 Point-of-Care Molecular Diagnostics Key Players in India
    • 10.3 India Point-of-Care Molecular Diagnostics Market Size by Type
    • 10.4 India Point-of-Care Molecular Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Point-of-Care Molecular Diagnostics Market Size (2014-2019)
    • 11.2 Point-of-Care Molecular Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Point-of-Care Molecular Diagnostics Market Size by Type
    • 11.4 Central & South America Point-of-Care Molecular Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Laboratories, Bayer Healthcare
      • 12.1.1 Abbott Laboratories, Bayer Healthcare Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Point-of-Care Molecular Diagnostics Introduction
      • 12.1.4 Abbott Laboratories, Bayer Healthcare Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019))
      • 12.1.5 Abbott Laboratories, Bayer Healthcare Recent Development
    • 12.2 F. Hoffmann-La Roche AG
      • 12.2.1 F. Hoffmann-La Roche AG Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Point-of-Care Molecular Diagnostics Introduction
      • 12.2.4 F. Hoffmann-La Roche AG Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
      • 12.2.5 F. Hoffmann-La Roche AG Recent Development
    • 12.3 Becton, Dickinson and Company
      • 12.3.1 Becton, Dickinson and Company Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Point-of-Care Molecular Diagnostics Introduction
      • 12.3.4 Becton, Dickinson and Company Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
      • 12.3.5 Becton, Dickinson and Company Recent Development
    • 12.4 BioMerieux
      • 12.4.1 BioMerieux Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Point-of-Care Molecular Diagnostics Introduction
      • 12.4.4 BioMerieux Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
      • 12.4.5 BioMerieux Recent Development
    • 12.5 Bio-Rad Laboratories, Inc.
      • 12.5.1 Bio-Rad Laboratories, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Point-of-Care Molecular Diagnostics Introduction
      • 12.5.4 Bio-Rad Laboratories, Inc. Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
      • 12.5.5 Bio-Rad Laboratories, Inc. Recent Development
    • 12.6 Cepheid, Inc.
      • 12.6.1 Cepheid, Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Point-of-Care Molecular Diagnostics Introduction
      • 12.6.4 Cepheid, Inc. Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
      • 12.6.5 Cepheid, Inc. Recent Development
    • 12.7 Danaher Corporation
      • 12.7.1 Danaher Corporation Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Point-of-Care Molecular Diagnostics Introduction
      • 12.7.4 Danaher Corporation Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
      • 12.7.5 Danaher Corporation Recent Development
    • 12.8 Johnson and Johnson
      • 12.8.1 Johnson and Johnson Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Point-of-Care Molecular Diagnostics Introduction
      • 12.8.4 Johnson and Johnson Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
      • 12.8.5 Johnson and Johnson Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system.
      Increased need for accurate and faster testing methods and results for the molecular tests is expected to propel the market growth.
      In 2018, the global Point-of-Care Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Point-of-Care Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Molecular Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Abbott Laboratories, Bayer Healthcare
      F. Hoffmann-La Roche AG
      Becton, Dickinson and Company
      BioMerieux
      Bio-Rad Laboratories, Inc.
      Cepheid, Inc.
      Danaher Corporation
      Johnson and Johnson

      Market segment by Type, the product can be split into
      PCR-based
      Genetic Sequencing-based
      Hybridization-based
      Microarray-based

      Market segment by Application, split into
      Infectious Diseases
      Oncology
      Hematology
      Prenatal Testing
      Endocrinology
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Point-of-Care Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
      To present the Point-of-Care Molecular Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Point-of-Care Molecular Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now